- Report
- December 2023
- 200 Pages
Global
From €4753EUR$5,000USD£4,077GBP
- Report
- December 2023
- 200 Pages
Global
From €4753EUR$5,000USD£4,077GBP
- Report
- December 2023
- 200 Pages
Global
From €4753EUR$5,000USD£4,077GBP
- Report
- January 2024
- 150 Pages
Global
From €4611EUR$4,850USD£3,955GBP
- Report
- November 2023
- 150 Pages
Global
From €4611EUR$4,850USD£3,955GBP
- Report
- March 2024
- 184 Pages
Global
From €3208EUR$3,374USD£2,751GBP
€3564EUR$3,749USD£3,057GBP
- Report
- May 2023
- 190 Pages
Global
From €2329EUR$2,450USD£1,998GBP
- Report
- April 2024
- 138 Pages
Global
From €3707EUR$3,899USD£3,179GBP
- Report
- April 2024
- 137 Pages
Global
From €3707EUR$3,899USD£3,179GBP
- Report
- March 2024
- 148 Pages
Global
From €3707EUR$3,899USD£3,179GBP
- Report
- March 2024
- 144 Pages
Global
From €3707EUR$3,899USD£3,179GBP
- Report
- November 2023
- 142 Pages
Global
From €2376EUR$2,499USD£2,038GBP
- Report
- November 2023
- 138 Pages
Global
From €2376EUR$2,499USD£2,038GBP
- Report
- May 2024
- 192 Pages
Global
From €4706EUR$4,950USD£4,036GBP
- Report
- May 2024
- 196 Pages
Global
From €4706EUR$4,950USD£4,036GBP
- Report
- May 2024
- 179 Pages
Global
From €4706EUR$4,950USD£4,036GBP
- Report
- May 2024
- 184 Pages
Global
From €4706EUR$4,950USD£4,036GBP
- Report
- May 2024
- 299 Pages
Global
From €5181EUR$5,450USD£4,444GBP
- Report
- May 2024
- 196 Pages
Global
From €5324EUR$5,600USD£4,566GBP
- Report
- May 2024
- 93 Pages
Global
From €5324EUR$5,600USD£4,566GBP
The Cardiovascular Drugs market is a segment of the pharmaceutical industry that focuses on the development and production of drugs used to treat cardiovascular diseases. These drugs are used to treat conditions such as hypertension, coronary artery disease, congestive heart failure, and arrhythmias. Cardiovascular drugs are also used to reduce the risk of stroke, heart attack, and other cardiovascular events.
The market is composed of a variety of companies, ranging from large multinationals to small start-ups. Major players in the market include Pfizer, Merck, Novartis, Sanofi, and Bristol-Myers Squibb. These companies are involved in the research, development, and production of cardiovascular drugs. Additionally, there are a number of smaller companies that specialize in the production of generic cardiovascular drugs. These companies include Teva Pharmaceuticals, Mylan, and Sun Pharmaceuticals. Show Less Read more